Baillie Gifford & Company Holding in Illumina (ILMN) Upped by $22.86 Million

July 18, 2017 - By Dolores Ford

Investors sentiment decreased to 0.67 in Q4 2016. Its down 0.40, from 1.07 in 2016Q3. It worsened, as 76 investors sold ILMN shares while 203 reduced holdings. 54 funds opened positions while 134 raised stakes. 133.90 million shares or 0.79% less from 134.97 million shares in 2016Q3 were reported. Moreover, Us Bankshares De has 0% invested in Illumina, Inc. (NASDAQ:ILMN). First Eagle Invest Mgmt Ltd Liability reported 0% of its portfolio in Illumina, Inc. (NASDAQ:ILMN). 3,281 are owned by First Foundation. 7,200 were accumulated by Oak Assoc Ltd Oh. Flow Traders Us Ltd Liability Company stated it has 93 shares or 0% of all its holdings. Dimensional Fund Advisors Limited Partnership reported 255,908 shares. Lombard Odier Asset (Europe) reported 0.08% in Illumina, Inc. (NASDAQ:ILMN). Blackrock Gp Limited reported 1.15 million shares stake. Chevy Chase Trust holds 0.18% in Illumina, Inc. (NASDAQ:ILMN) or 260,529 shares. Vigilant Mngmt Ltd stated it has 225 shares or 0.01% of all its holdings. Allianz Asset Mngmt Ag holds 0.02% or 168,592 shares in its portfolio. Caisse De Depot Et Placement Du Quebec reported 12,195 shares stake. Korea Invest invested in 0.01% or 17,873 shares. Laurion Capital Mgmt LP holds 0.01% or 11,900 shares in its portfolio. Conning reported 0.02% in Illumina, Inc. (NASDAQ:ILMN).

Since January 30, 2017, it had 0 buys, and 23 sales for $15.50 million activity. Shares for $494,633 were sold by BOWMAN A BLAINE on Wednesday, March 8. 1,672 shares were sold by OSTADAN OMEAD, worth $311,159 on Monday, May 8. 600 Illumina, Inc. (NASDAQ:ILMN) shares with value of $97,677 were sold by BRADBURY DANIEL. FLATLEY JAY T also sold $3.60 million worth of Illumina, Inc. (NASDAQ:ILMN) on Tuesday, June 6. Bouchard Michel also sold $44,012 worth of Illumina, Inc. (NASDAQ:ILMN) on Thursday, June 8. 2,000 shares were sold by Stapley Marc, worth $341,699 on Monday, June 12. Another trade for 825 shares valued at $144,185 was sold by ARNOLD FRANCES.

Baillie Gifford & Company increased its stake in Illumina (ILMN) by 0.96% based on its latest 2016Q4 regulatory filing with the SEC. Baillie Gifford & Company bought 178,559 shares as the company’s stock rose 8.35% with the market. The institutional investor held 18.77 million shares of the capital goods company at the end of 2016Q4, valued at $2.40B, up from 18.59 million at the end of the previous reported quarter. Baillie Gifford & Company who had been investing in Illumina for a number of months, seems to be bullish on the $24.89 billion market cap company. The stock declined 0.59% or $1.01 reaching $170.73 on the news. About 1 shares traded. Illumina, Inc. (NASDAQ:ILMN) has risen 28.24% since July 18, 2016 and is uptrending. It has outperformed by 11.54% the S&P500.

Baillie Gifford & Company, which manages about $60.79 billion US Long portfolio, decreased its stake in Dolby Laboratories ‘A’ (NYSE:DLB) by 5.30M shares to 260,767 shares, valued at $11.78M in 2016Q4, according to the filing. It also reduced its holding in Markel Corp (NYSE:MKL) by 334,864 shares in the quarter, leaving it with 569,135 shares, and cut its stake in Apache Corp (NYSE:APA).

More notable recent Illumina, Inc. (NASDAQ:ILMN) news were published by: which released: “Better Buy: Illumina, Inc. vs. Roche Holding Ltd. (ADR)” on July 01, 2017, also with their article: “Form 4 ILLUMINA INC For: Jul 14 Filed by: Stapley Marc” published on July 18, 2017, published: “3 Charts That Every Illumina, Inc. Investor Needs to See” on July 05, 2017. More interesting news about Illumina, Inc. (NASDAQ:ILMN) were released by: and their article: “Illumina updates on cancer companion diagnostic test kit” published on June 30, 2017 as well as‘s news article titled: “BRIEF-Inno-Gene says units reach agreement with Illumina over patent dispute” with publication date: June 26, 2017.

Illumina, Inc. (NASDAQ:ILMN) Ratings Coverage

Among 24 analysts covering Illumina Inc (NASDAQ:ILMN), 11 have Buy rating, 3 Sell and 10 Hold. Therefore 46% are positive. Illumina Inc had 56 analyst reports since July 22, 2015 according to SRatingsIntel. As per Wednesday, July 22, the company rating was downgraded by Janney Capital. Mizuho downgraded Illumina, Inc. (NASDAQ:ILMN) rating on Tuesday, October 6. Mizuho has “Neutral” rating and $150 target. First Analysis downgraded Illumina, Inc. (NASDAQ:ILMN) rating on Wednesday, November 2. First Analysis has “Underweight” rating and $116 target. The stock of Illumina, Inc. (NASDAQ:ILMN) has “Underweight” rating given on Wednesday, December 7 by Morgan Stanley. The rating was downgraded by Bank of America on Tuesday, April 19 to “Neutral”. The firm has “Neutral” rating by CL King given on Monday, August 22. The stock of Illumina, Inc. (NASDAQ:ILMN) has “Buy” rating given on Tuesday, October 6 by Stifel Nicolaus. The stock has “Buy” rating by Cowen & Co on Monday, July 10. The company was maintained on Tuesday, October 11 by Canaccord Genuity. Canaccord Genuity downgraded Illumina, Inc. (NASDAQ:ILMN) rating on Thursday, February 4. Canaccord Genuity has “Hold” rating and $160 target.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.